Novo Nordisk, one of the world leaders in diabetes treatment, announced that it had extended its contract with Charlie Kimball for several years. Good news for the young 26-year-old American, who will play his second season next year in IndyCar at the wheel of a car entered by Novo Nordisk Chip Ganassi Racing.
Comments
*The space reserved for logged in users. Please connect to be able to respond or post a comment!
0 Comment (s)
To write a comment
0 View comments)